An Open-label, Dose-Finding, Phase 1/2 Study to Evaluate the Safety and Tolerability of a Single Intravenous Dose of LY3884961 in Patients with Peripheral Manifestations of Gaucher Disease
Clinical Trial Grant
Administered By
Pediatrics, Medical Genetics
Awarded By
Lilly USA, LLC
Start Date
May 2, 2023
End Date
September 1, 2026
Administered By
Pediatrics, Medical Genetics
Awarded By
Lilly USA, LLC
Start Date
May 2, 2023
End Date
September 1, 2026